In this study, a target gene of miR-1/194/206-3p was MFAP4, which was recently identified as a biomarker for hepatic fibrosis and has been used to detect high-risk patients with severe fibrosis stages among hepatitis C patients48. This evidence concerns the gene MFAP4 and Hepatic fibrosis.